![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant
Fabio Scarpa, Ilenia Azzena, Alessandra Ciccozzi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13573-13573
Open Access | Times Cited: 8
Fabio Scarpa, Ilenia Azzena, Alessandra Ciccozzi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13573-13573
Open Access | Times Cited: 8
Showing 8 citing articles:
Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022–August 2023
Jiratchaya Puenpa, Jira Chansaenroj, Kamol Suwannakarn, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Jiratchaya Puenpa, Jira Chansaenroj, Kamol Suwannakarn, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
SARS-CoV-2 XEC: A Genome-Based Survey
Fabio Scarpa, Francesco Branda, Giancarlo Ceccarelli, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 253-253
Open Access
Fabio Scarpa, Francesco Branda, Giancarlo Ceccarelli, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 253-253
Open Access
Update of the Genetic Variability of Monkeypox Virus Clade IIb Lineage B.1
Fabio Scarpa, Ilenia Azzena, Alessandra Ciccozzi, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1874-1874
Open Access | Times Cited: 3
Fabio Scarpa, Ilenia Azzena, Alessandra Ciccozzi, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1874-1874
Open Access | Times Cited: 3
On the SARS-CoV-2 Variants
Fabio Scarpa, Francesco Branda, Nicola Petrosillo, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 2, pp. 289-297
Open Access | Times Cited: 2
Fabio Scarpa, Francesco Branda, Nicola Petrosillo, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 2, pp. 289-297
Open Access | Times Cited: 2
Properties and Mechanisms of Deletions, Insertions, and Substitutions in the Evolutionary History of SARS-CoV-2
Igor B. Rogozin, Andreu Saura, Eugenia Poliakov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3696-3696
Open Access | Times Cited: 2
Igor B. Rogozin, Andreu Saura, Eugenia Poliakov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3696-3696
Open Access | Times Cited: 2
Exploring B-cell Epitope Conservation and Antigenicity Shift in Current COVID-19 Variants: Analyzing Spike-Antibody Interactions for Therapeutic Uses
Alankar Roy, Ishani Paul, T. Manna Paul, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 739, pp. 150948-150948
Closed Access
Alankar Roy, Ishani Paul, T. Manna Paul, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 739, pp. 150948-150948
Closed Access
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access
Longitudinal Analysis of Neutralizing Antibodies Against SARS-CoV-1 and Different SARS-CoV-2 Strains in Breakthrough and Unvaccinated Covid-19 Patients in Thailand
Prapassorn Poolchanuan, Vichapon Tiacharoen, Adul Dulsuk, et al.
(2024)
Closed Access
Prapassorn Poolchanuan, Vichapon Tiacharoen, Adul Dulsuk, et al.
(2024)
Closed Access